Do you want to read an article? Please log in or register.
Longitudinal variability of lipoprotein(a) in youth-onset type 1 diabetes: implications for cardiovascular risk stratification
Cardiovascular Risk and Diseases
Related content
COMMENTED
Cardiovascular Risk and Diseases
Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Patsoukaki V, Lind L, Lampa E, Radhi S, Eeg-Olofsson K, Eliasson B, Eriksson JW
doi: 10.1016/S2213-8587(25)00165-2
Cardiovascular Risk and Diseases
Low serum 1,5-anhydroglucitol is associated with increased risk of all-cause and cardiovascular mortality in type 2 diabetes: A real-world cohort study
Diabetes Obes Metab
Ni J, Chen L, Su H, Cai J, Wang C, Lu W, Wang Y, Lu J, Xia T, Zhou J
doi: 10.1111/dom.70214
Cardiovascular Risk and Diseases
Cardiorenal risk stratification in high-risk type 2 diabetes using a simple clinical score: findings from the ELIXA trial
Front Endocrinol (Lausanne)
Jiang W, Wang J, Li J, Li Y, Zhang Y, Xu J, Zhang J, Gao Z, Cheng J, Yang J, Chang B
doi: 10.3389/fendo.2026.1768816
Cardiovascular Risk and Diseases
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial
JAMA Cardiol
Mulvagh SL, Inzucchi SE, Marx N, Poulter NR, Deanfield JE, Pop-Busui R, Emerson SS, Mann JFE, Engelmann MDM, Hovingh GK, Mandavya K, Davicevic-Elez Z, Jeppesen OK, Lorenzatti A, Oguz A, Mankovsky B, Deerochanawong C, Gorgojo-Martinez JJ, Ji L, Bain SC, McGuire DK, Buse JB, SOUL Study Group
doi: 10.1001/jamacardio.2026.0245
COMMENTED
Heart, Artery and Coronary Diseases
Heterogeneity of Cardiovascular Effects of Second-Line Glucose-Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
J Am Heart Assoc
Deng Y, Polley EC, Herrin J, Swarna KS, Kent DM, Ross JS, Maron BA, Mickelson MM, McCoy RG
doi: 10.1161/JAHA.124.040217
Cardiovascular Risk and Diseases
Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target Trial
J Am Heart Assoc
Zehra A, Deng Y, Swarna KS, Herrin J, Polley EC, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Brito JP, Montori VM, Borah BJ, Maron BA, Mickelson MM, McCoy RG
doi: 10.1161/JAHA.125.046238
Myocardial Infarction
Comparison of incidence patterns and risk profiles of ST-elevation and non-ST-elevation myocardial infarction in type 1 diabetes in Finland: a nationwide cohort study
Lancet Diabetes Endocrinol
Smidtslund P, Harjutsalo V, Thorn V, Jansson Sigfrids F, Groop PH, Thorn LM, FinnDiane Study Group
doi: 10.1016/S2213-8587(25)00368-7
Cardiovascular Risk and Diseases
Maternal Diabetes and Risk of Early-Onset Cardiovascular Diseases in Offspring
JAMA Cardiol
Mo X, Janszky I, Wang H, Yang F, Möller J, Liang Y, László KD
doi: 10.1001/jamacardio.2026.0915
Heart, Artery and Coronary Diseases
Waist-to-Height Ratio Is Associated With the Risk of Coronary Artery Disease in Type 1 Diabetes: A 19-Year Cohort Study
Diabetes Care
Parente EB, Jansson Sigfrids F, Groop PH, Thorn LM, Sandholm N, Harjutsalo V, FinnDiane Study Group*
doi: 10.2337/dc25-2811